Karam Salama, DrPH

Associate Director, Field Medical Affairs
Regeneron Inc
Corona, California, United States

Presentation(s):

• Dupilumab Is Effective in Treating EoE in Patients Weighing 15 Kg and above: Results from the Phase 3 KIDS Study

  Monday, April 28, 2025
  11:30am – 11:45am HST

  Disclosure(s): Regeneron Pharmaceuticals Inc. (Ongoing) (Products/Services: Employment with an ineligible company)

• Impact Of Dupilumab on Caregiver-Reported Signs Of EOE, Using PESQ-C OVER 52 WEEKS: Results from The Phase 3 EOE Kids Study

  Monday, April 28, 2025
  11:45am – 12:00pm HST

  Disclosure information not submitted.